🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalMedical tourism for GLP-1 — anyone have experience? Page 5

Medical tourism for GLP-1 — anyone have experience?

ChrisMacros Sat, Apr 26, 2025 at 4:52 AM 36 replies 2,034 viewsPage 5 of 8
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
May 1, 2025 at 9:07 AM#21
BenResearch_OR said:
Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

This is my experience too, for whatever a second data point is worth.

Last edited: May 1, 2025 at 11:07 AM
38 13PharmD_Rodriguez, julia.endo, JessicaM_2024 and 35 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
May 3, 2025 at 12:35 AM#22
BenResearch_OR said:
Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

Coming at BenResearch_OR’s question from a different direction. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

Last edited: May 3, 2025 at 5:35 AM
37 12tyler_CSCS, VanRx_Mike, steve_okc and 34 others
Reply Quote Save Share Report
bri_stats
Member
789
3,456
May 2024
Seattle, WA
May 4, 2025 at 4:02 PM#23

One concrete data point for the thread. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

36 11TomFromTexas, mike.trainer_LA, sarah_nash92 and 33 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
MariaRD
Member
823
4,567
Jun 2024
New Mexico
May 6, 2025 at 7:28 AM#24

A narrower follow-up, since the general answer is now clear:

How would you tell the difference between that and the alternative explanation?

Last edited: May 6, 2025 at 8:28 AM
35 10rick_sfbay, maria_elpaso, anders_CPH and 32 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
May 7, 2025 at 10:54 PM#25
bri_stats said:
Say what you would expect to see if you were wrong, before you look.

Pushing back on bri_stats here. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

Last edited: May 8, 2025 at 4:54 AM
34 9mike_mealprep, NicoleRaleigh, james_edin and 31 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register